title: Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care.
authors.affiliation: Women's Health Program, University Health Network, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Angela M
authors.initials: AM
authors.lastname: Cheung
authors.forename: Denice S
authors.initials: DS
authors.lastname: Feig
authors.forename: Moira
authors.initials: M
authors.lastname: Kapral
authors.forename: Natalia
authors.initials: N
authors.lastname: Diaz-Granados
authors.forename: Sylvie
authors.initials: S
authors.lastname: Dodin
mesh_terms: D000368:Aged; D015519:Bone Density; D004164:Diphosphonates / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D050723:Fractures, Bone / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications* / Q000517:prevention & control*; D017698:Postmenopause; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D012307:Risk Factors; D016387:Women's Health
chemical_list: D004164:Diphosphonates; D004965:Estrogen Antagonists; D020849:Raloxifene Hydrochloride